Dyadic reports financial results for Q1, Q2 of 2009
30 Oct '09
1 min read
Dyadic International, Inc. announced financial results for the first and second quarters of 2009 as well as for the years ended December 31, 2008 and 2007. The financial information contained in this press release should be read in conjunction with the financial statements, footnotes and independent auditors' report which have been posted on the Pink Sheets website.
Dyadic's Chief Executive Officer, Mark Emalfarb, stated, “Today marks a significant milestone for Dyadic in becoming current with its financial reporting and being able to share its recent efforts to build the long-term viability of the company. We are committed to providing financial information on a timely basis going forward. As of today, Dyadic has a current cash position of approximately $9.6 million which is sufficient to conduct its operations. We are aggressively pursuing a variety of research and business collaborations to leverage our patented and proprietary technologies and to grow our industrial enzyme business including additional technology licensing deals, co-development of products and processes and enhancing our manufacturing capabilities.”